AUROBINDO PHARMA
Back to Balance Sheet
|
AUROBINDO PHARMA Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹48,492 Cr | ₹43,859 Cr | ₹39,213 Cr | ₹33,633 Cr | ₹33,401 Cr |
What is the latest Total Liabilities ratio of AUROBINDO PHARMA ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹48,492 Cr |
| Mar2024 | ₹43,859 Cr |
| Mar2023 | ₹39,213 Cr |
| Mar2022 | ₹33,633 Cr |
| Mar2021 | ₹33,401 Cr |
How is Total Liabilities of AUROBINDO PHARMA Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹48,492 Cr | 10.56 | |
| Mar2024 | ₹43,859 Cr | 11.85 | |
| Mar2023 | ₹39,213 Cr | 16.59 | |
| Mar2022 | ₹33,633 Cr | 0.69 | |
| Mar2021 | ₹33,401 Cr | - | |
Compare Total Liabilities of peers of AUROBINDO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AUROBINDO PHARMA | ₹66,704.9 Cr | -4.4% | -2.7% | -2.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹407,431.0 Cr | -0.4% | -0.1% | -2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹163,772.0 Cr | 0.9% | -3% | 0.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹137,884.0 Cr | 2% | 1.7% | 25.2% | Stock Analytics | |
| CIPLA | ₹107,503.0 Cr | -0.9% | -7.2% | -9.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,798.0 Cr | -0.6% | 6.8% | 2.7% | Stock Analytics | |
AUROBINDO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AUROBINDO PHARMA | -4.4% |
-2.7% |
-2.9% |
| SENSEX | -1.1% |
-1.2% |
5.9% |
You may also like the below Video Courses